RxDoctor Payments Data

Robert Causey, MD

Family Medicine · Aurora, MONPI 1033180963

Payments from drug & device makers

$598in general payments, 2019–2025

Across 33 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$138
  • AstraZeneca$112
  • Novo Nordisk$95
  • Dexcom, Inc.$93
  • GSK$42
  • Baxter Healthcare$36
  • plus $82 from 5 others

What the payments were for

  • Food & beverage$56294%
  • Other$366%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$598 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$396
Medicare patients
20
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide46$64,593
Trelegy ElliptaFluticasone/Umeclidin/Vilanter87$58,298
JardianceEmpagliflozin45$39,331
OzempicSemaglutide35$30,572
FarxigaDapagliflozin Propanediol47$28,790
Repatha SureclickEvolocumab26$17,672
MounjaroTirzepatide13$13,696
EliquisApixaban22$12,898
Stiolto RespimatTiotropium Br/Olodaterol Hcl19$11,773
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$10,833
Bydureon BciseExenatide Microspheres12$9,388
SymbicortBudesonide/Formoterol Fumarate30$9,293
Semglee (Yfgn) PenInsulin Glargine-Yfgn14$5,825
Bevespi AerosphereGlycopyrrolate/Formoterol Fum12$5,157
Fluticasone-VilanterolFluticasone/Vilanterol12$3,891

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$30$78,28959 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$42$72,686124 claims
AstraZenecaFarxiga, Symbicort, Bevespi Aerosphere$112$43,24089 claims
Novo NordiskOzempic$95$30,57235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Aurora

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →